In this study, all tested patients had a detectable response to glutamic acid decarboxylase (GAD), an autoAg in T1D, with CSFE dilution assay, that was revealed only in half of the patients by 3H-thymidine incorporation. This evidence concerns the gene GAD1 and type 1 diabetes mellitus.